首頁 > 市場調查報告書 > 醫療設備

醫學影像診斷 CT/MRI/X光

市場調查報告書

商品編碼

1732178

全球 CT 大腸造影市場規模（按類型、應用、最終用戶、地區和預測）：

Global CT Colonography Market Size By Type, By Application, By End-User, By Geographic Scope And Forecast

出版日期: 2025年04月29日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

CT結腸成像市場規模及預測

近年來，全球CT結腸成像市場規模一直保持中等速度成長，成長率顯著，市場估計和預測預計2026年至2032年間將大幅成長。

推動全球CT結腸成像市場的因素

CT結腸成像市場受多種因素驅動，其中包括：

大腸直腸癌發生率不斷上升：大腸直腸癌是全球最常見的癌症之一。此疾病發生率的不斷上升推動了對高效篩檢技術的需求，例如CT結腸成像，它可以識別癌前息肉和早期癌症。

影像學發展：隨著CT影像技術的發展，包括解析度的提高、掃描時間的縮短以及3D成像能力的增強，CT結腸成像的準確性和有效性正在不斷提高。這些發展使得CT檢查對病人和醫護人員更具吸引力。

CT大腸造影是一種非侵入性檢查，這意味著它比傳統大腸鏡檢查風險更低，創傷性也更小。它也不需要麻醉。正因為它是非侵入性的，所以那些不願意接受傳統大腸鏡檢查的人應該選擇它。

大眾對早期癌症檢測的認知度不斷提升：隨著大眾對大腸癌早期檢測和篩檢重要性的認知不斷加深，對篩檢技術的需求也日益成長。醫療保健機構正在透過宣傳活動和教育項目，大力宣傳早期檢測的益處，這推動了CT結腸成像應用的普及。

支持性監管指南：市場受到支持CT結腸成像作為結直腸癌有效篩檢方法的指南和建議的驅動。這些建議來自醫療機構和組織，例如美國癌症協會和美國預防服務工作小組。

老化：隨著全球人口老化加劇，罹患大腸癌的風險也隨之增加，因此定期篩檢尤其重要。隨著人口老化，CT結腸造影作為篩檢手段的需求預計將持續成長。

成本效益和可及性：考慮到鎮靜、恢復時間等因素，CT結腸造影可能比傳統大腸鏡檢查更經濟。現代成像中心的可用性和可及性的提高也是推動市場擴張的因素。

預防性醫療保健的普及率不斷提升：隨著預防性醫療保健日益成為趨勢，人們越來越積極主動地定期進行健康檢查，以便及早發現疾病。對CT結腸成像等篩檢技術的需求正反映了這種醫療保健理念的轉變。

與人工智慧 (AI) 的整合：透過增強影像處理、更準確地檢測異常並減少假陽性和假陰性的機會，CT 成像中 AI 和機器學習的整合將提高 CT 結腸造影的準確性和效率。

醫療基礎設施的擴展：醫療系統的現代化和擴展將使CT結腸造影等先進的診斷工具更容易獲得，尤其是在開發中國家。醫療設施的增加和診斷能力的提高將推動市場成長。

限制全球CT結腸成像市場的因素

CT結腸成像市場面臨許多限制因素和挑戰，包括：

初始設置成本高：CT結腸成像需要在軟體、硬體和培訓方面投入大量初始資金。高昂的設置成本可能會對醫療機構造成阻礙力，尤其是在報銷政策和醫療預算嚴格的地區。

報銷政策有限：CT結腸造影的付款計劃因付款方和地區而異。在某些地區，其報銷金額可能低於其他CRC篩檢程序，例如大腸鏡檢查。由於報銷金額不足或不公平，醫療保健提供者可能不願意推薦CT大腸造影作為篩檢選項。

技術複雜性：CT結腸成像需要高度專業的工具和知識以及先進的成像技術。準確執行和解讀CTC檢查需要對醫療保健專業人員進行培訓。技術複雜性可能會限制CTC的採用和使用，尤其是在缺乏合格人員的地區。

輻射暴露問題：儘管劑量低於常規CT掃描，但CT結腸造影仍涉及電離輻射暴露。患者，尤其是對輻射敏感或有輻射暴露史的患者，可能會因為擔心輻射暴露而猶豫是否接受CTC篩檢。

大腸直腸病變可視化不足：雖然結直腸細胞學檢查 (CTC) 是識別大多數結直腸病變的有效工具，但它可能會漏掉較小或扁平的病變，尤其是在存在殘留糞便或糞便準備不足的情況下。病變可視化不足可能導致假陰性結果，從而降低 CTC 作為篩檢方法的有效性。

腸道準備挑戰：準確的CT結腸成像取決於充分的腸道準備。然而，有些人腸道準備有困難，這可能導致影像品質和診斷準確性不理想。患者在腸道準備過程中感到不適和困難，可能會阻礙他們參與CTC篩檢計畫。

診斷準確性和假陽性：與任何篩檢方法一樣，CT大腸造影的診斷準確性和特異性有限。假陽性結果可能導致不必要的後續檢查和程序，例如，由於檢測到結腸外異常或非腫瘤性病變，從而增加醫療成本並加劇患者的焦慮。

患者的接受度和偏好：許多因素會影響患者對CT結腸造影的接受度，包括侵入性、不適感和隱私問題。患者可能更傾向於非侵入性篩檢方法，例如糞便檢驗，這可能會影響CT結腸造影的接受度和接受度。

監管要求和品質保證：為確保病人安全和診斷準確性，CT結腸成像必須遵守品質保證程序和監管標準。提供CTC服務的醫療機構可能需要承擔額外的管理成本和工作量，以遵守監管要求並維持品質標準。

來自其他篩檢方式的競爭：大腸鏡檢查、乙狀結腸鏡檢查和糞便免疫化學檢查(FIT) 是 CT 大腸造影面臨的其他 CRC篩檢技術。 CTC 的需求可能受所選篩檢方式的影響，而篩檢方式的選擇取決於患者偏好、醫師建議和資源可用性。

Developments in Imaging Technology: The precision and efficacy of CT colonography are increased by technological developments in CT imaging, which include increased resolution, quicker scanning times, and better 3D imaging capabilities. Patients and healthcare professionals find the process more appealing as a result of these developments.

The non-invasive nature of CT colonography makes it less risky of problems and less invasive than traditional colonoscopy. It also doesn't require anesthesia. Because it is non-invasive, people who are hesitant to have a traditional colonoscopy should choose this option.

Growing Public Awareness of Early Cancer Detection: The need for screening techniques is boosted by a greater understanding of the significance of early colorectal cancer detection and screening. Healthcare organizations are emphasizing the advantages of early detection through their campaigns and education programs, which is driving increasing the use of CT colonography.

Supportive Regulatory Guidelines: The market is driven by guidelines and recommendations that support CT colonography as an effective screening approach for colorectal cancer. These recommendations come from healthcare authorities and organizations such as the American Cancer Society and the U.S. Preventive Services Task Force.

Aging Population: Regular screening is especially important since the world's aging population is more likely to get colorectal cancer. The need for CT colonography as a screening technique is anticipated to increase with the aging population.

Cost-Effectiveness and Accessibility: When taking into account aspects like sedation and recovery time, CT colonography may prove to be more economical than conventional colonoscopy. The availability and accessibility of modern imaging centers has increased, which is another factor driving market expansion.

Growing Adoption of Preventive Healthcare: People are becoming more proactive about getting regular health tests to identify ailments early on, as part of a growing trend towards preventive healthcare. The need for screening techniques like as CT colonography is being answered by this change in healthcare philosophy.

Integration with Artificial Intelligence (AI): By enhancing picture processing, more accurately detecting anomalies, and lowering the possibility of false positives and negatives, the integration of AI and machine learning in CT imaging improves the accuracy and efficiency of CT colonography.

Expansion of Healthcare Infrastructure: Modernizing and expanding the healthcare system makes advanced diagnostic tools like CT colonography more accessible, particularly in developing nations. Growth in the market is driven by better healthcare facilities and diagnostic capabilities.

Global CT Colonography Market Restraints

Several factors can act as restraints or challenges for the CT Colonography Market. These may include:

High Initial Setup Costs: A substantial initial investment in software, hardware, and training is necessary for the adoption of CT colonography. For healthcare facilities, high setup costs might be a deterrent, particularly in areas with tight reimbursement policies or healthcare budgets.

Limited Reimbursement Policies: Payment plans differ depending on the payer and the region for CT colonography procedures. Reimbursement might be less in some places than for other colorectal cancer screening techniques like colonoscopy. Healthcare practitioners may be dissuaded from recommending CT colonography as a screening option by inadequate or uneven payment.

Technological Complexity: CT colonography calls very specific tools and knowledge, as well as sophisticated imaging procedures. Accurate performance and interpretation of CTC scans require training for healthcare workers. The adoption and availability of CTC may be restricted by its technical complexity, especially in environments where access to qualified individuals is limited.

Radiation Exposure Concerns: Although at lower doses than typical CT scans, CT colonography entails exposure to ionizing radiation. Some patients may be deterred from receiving CTC screening due to concerns about radiation exposure, especially if they are radiation sensitive or have a history of radiation exposure.

Inadequate Visualization of Colonic Lesions: Although colonic tissue cytometry (CTC) is a useful tool for identifying the majority of colonic lesions, it can overlook small or flat lesions, particularly when there is leftover feces or insufficient stool preparation. The completeness of the lesions' visibility can cause false-negative results and compromise the validity of CTC as a screening method.

Challenges with intestinal Preparation: Correct CT colonography depends on adequate intestinal preparation. However, some individuals may find it difficult to prepare their bowels, which might result in less than ideal image quality and diagnostic precision. Participation in CTC screening programs may be discouraged by the discomfort and difficulty that patients experience during bowel preparation.

Diagnostic Accuracy and False Positives: The diagnostic accuracy and specificity of CT colonography are limited, much as those of any screening technique. False-positive results can result in needless follow-up tests and actions, raising healthcare expenses and patient worry. Examples of these include the discovery of extracolonic abnormalities or non-neoplastic lesions.

Patient acceptability and Preference: Depending on a number of variables, including perceived invasiveness, discomfort, and privacy concerns, a patient's acceptability of CT colonography may differ. The preference of certain patients for non-invasive screening techniques, such as stool-based testing, may impact the acceptance and utilization of CTC.

Regulatory Requirements and Quality Assurance: To guarantee patient safety and diagnostic precision, CT colonography must adhere to quality assurance procedures and regulatory standards. Healthcare facilities that provide CTC services may incur additional administrative costs and hassles in order to comply with regulatory requirements and uphold quality standards.

Competition from Alternative Screening Modalities: Colonoscopy, sigmoidoscopy, and fecal immunochemical testing (FIT) are some of the other colorectal cancer screening techniques that CT colonography faces off against. The demand for CTC may be impacted by the screening modality selected, which may be determined by patient preferences, doctor recommendations, and resource availability.

Global CT Colonography Market Segmentation Analysis

The Global CT Colonography Market is Segmented on the basis of Type, Application, End-User, and Geography.

CT Colonography Market, By Type

Primary CT Colonography: Refers to the use of CT colonography as the primary screening method for colorectal cancer detection and diagnosis.
Computer-Aided Detection (CAD) Systems: Refers to the use of computer algorithms to assist radiologists in detecting abnormalities in CT colonography images, increasing diagnostic accuracy.
CT Colonography Workstations: Dedicated workstations equipped with specialized software for processing and interpreting CT colonography images.

CT Colonography Market, By Application

Screening: CT colonography used as a non-invasive screening method for detecting colorectal polyps and cancer in asymptomatic individuals.
Diagnosis: CT colonography employed for diagnosing colorectal abnormalities, including polyps, tumors, and inflammatory conditions, in symptomatic patients or those with a positive fecal occult blood test (FOBT) result.
Monitoring: CT colonography used for monitoring the progression or regression of colorectal lesions over time, particularly in patients with a history of colorectal neoplasia.

CT Colonography Market, By End-User

Hospitals and Clinics: Radiology departments, gastroenterology clinics, and outpatient imaging centers offering CT colonography services to patients.
Diagnostic Imaging Centers: Specialized facilities focused on providing imaging services, including CT colonography, to patients referred by primary care physicians or specialists.
Research Institutes: Academic and research institutions conducting clinical studies and trials to evaluate the efficacy, safety, and cost-effectiveness of CT colonography for colorectal cancer screening and diagnosis.

CT Colonography Market, By Geography

North America: Includes the United States and Canada, characterized by a high prevalence of colorectal cancer and extensive adoption of CT colonography as a screening and diagnostic tool.
Europe: Includes countries such as Germany, the UK, France, Italy, and Spain, where national screening programs and guidelines support the use of CT colonography alongside other colorectal cancer screening modalities.
Asia-Pacific: Includes China, Japan, India, South Korea, and Australia, where the adoption of CT colonography is gradually increasing due to rising awareness of colorectal cancer and improvements in healthcare infrastructure.
Latin America: Includes Brazil, Mexico, and other countries in Central and South America, with a growing emphasis on preventive healthcare and cancer screening programs.
Middle East and Africa: Includes countries such as Saudi Arabia, UAE, South Africa, and others, where efforts to improve cancer detection and management drive the adoption of CT colonography.

Key Players

The major players in the CT Colonography Market are:
Siemens Healthineers
Canon Medical Systems Corporation
Philips Healthcare
GE Healthcare
Shimadzu Corporation
Fujifilm Corporation
Hitachi Ltd.
Samsung Electronics Co. Ltd.
MILESTONE Srl
Neusoft Medical Systems Co.Ltd.

1 INTRODUCTION OF GLOBAL CT COLONOGRAPHY MARKET

1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL CT COLONOGRAPHY MARKET OUTLOOK

4.1 Overview
4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework

5 GLOBAL CT COLONOGRAPHY MARKET, BY TYPE

5.1 Primary CT Colonography
5.2 Computer-Aided Detection (CAD) Systems
5.3 CT Colonography Workstations

6 GLOBAL CT COLONOGRAPHY MARKET, BY APPLICATION

6.1 Screening
6.2 Diagnosis
6.3 Monitoring

7 GLOBAL CT COLONOGRAPHY MARKET, BY END-USER

7.1 Hospitals and Clinics
7.2 Diagnostic Imaging Centers
7.3 Research Institutes

8 GLOBAL CT COLONOGRAPHY MARKET, BY GEOGRAPHY

8.1 Overview
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
- 8.2.3 Mexico
8.3 Europe
- 8.3.1 Germany
- 8.3.2 U.K.
- 8.3.3 France
- 8.3.4 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Argentina
8.6 Rest of the World

9 GLOBAL CT COLONOGRAPHY MARKET COMPETITIVE LANDSCAPE

9.1 Overview
9.2 Company Market ranking
9.3 Vendor Landscape
9.4 Key Development Strategies

10 COMPANY PROFILES

10.1 Siemens Healthineers
- 10.1.1 Overview
- 10.1.2 Financial Performance
- 10.1.3 Product Outlook
- 10.1.4 Key Developments
10.2 Canon Medical Systems Corporation
- 10.2.1 Overview
- 10.2.2 Financial Performance
- 10.2.3 Product Outlook
- 10.2.4 Key Developments
10.3 Philips Healthcare
- 10.3.1 Overview
- 10.3.2 Financial Performance
- 10.3.3 Product Outlook
- 10.3.4 Key Developments
10.4 GE Healthcare
- 10.4.1 Overview
- 10.4.2 Financial Performance
- 10.4.3 Product Outlook
- 10.4.4 Key Developments
10.5 Shimadzu Corporation
- 10.5.1 Overview
- 10.5.2 Financial Performance
- 10.5.3 Product Outlook
- 10.5.4 Key Developments
10.6 Fujifilm Corporation
- 10.6.1 Overview
- 10.6.2 Financial Performance
- 10.6.3 Product Outlook
- 10.6.4 Key Developments
10.8 Hitachi Ltd.
- 10.8.1 Overview
- 10.8.2 Financial Performance
- 10.8.3 Product Outlook
- 10.8.4 Key Developments
10.8 Samsung Electronics Co. Ltd.
- 10.8.1 Overview
- 10.8.2 Financial Performance
- 10.8.3 Product Outlook
- 10.8.4 Key Developments
10.10 MILESTONE Srl
- 10.10.1 Overview
- 10.10.2 Financial Performance
- 10.10.3 Product Outlook
- 10.10.4 Key Developments
10.10 Neusoft Medical Systems Co.Ltd.
- 10.10.1 Overview
- 10.10.2 Financial Performance
- 10.10.3 Product Outlook
- 10.10.4 Key Developments